Literature DB >> 14571698

Radiosurgery for recurring liver metastases after hepatectomy.

Peter Gunvén1, Henric Blomgren, Ingmar Lax.   

Abstract

BACKGROUND/AIMS: Most resected liver metastases from colorectal cancer recur. A minority of liver recurrences have been re-resected, but most re-resections fail and they decrease the postoperative performance status for a longer time than the initial resections, so that less demanding potentially curative treatments need evaluation.
METHODOLOGY: Four out of 5 liver-only recurrences after 18 consecutive liver resections were limited and suitable for radiosurgery. The patients were fixed in a frame and stereotactic irradiation with 20 Gy twice or 15 Gy three times was delivered to the tumors.
RESULTS: Limited side effects were seen, without medical need for hospital admission. Thirteen--101 months later, all treated tumors were locally controlled with complete radiologic remission of two of them. Only one patient recurred in the liver, with bilobar lesions preceded by extrahepatic spread. Neither recurrence would have been prevented by a rehepatectomy instead of irradiation. One patient died later tumor-free from stroke, two died from generalized tumors, and one remains in remission 101 months after radiosurgery.
CONCLUSIONS: Radiosurgery of liver tumors merits further study, and may offer a less demanding alternative to resection for selected liver tumors with the prospect of long-term survival.

Entities:  

Mesh:

Year:  2003        PMID: 14571698

Source DB:  PubMed          Journal:  Hepatogastroenterology        ISSN: 0172-6390


  7 in total

Review 1.  Establishing the Impact of Vascular Damage on Tumor Response to High-Dose Radiation Therapy.

Authors:  Katherine D Castle; David G Kirsch
Journal:  Cancer Res       Date:  2019-08-19       Impact factor: 12.701

2.  Undetectable late hepatic sequelae after hypofractionated stereotactic radiotherapy for liver tumors.

Authors:  Peter Gunvén; Eduard Jonas; Henric Blomgren; Eva Rutkowska; Kristin Karlsson; Ingmar Lax; Seymour Levitt
Journal:  Med Oncol       Date:  2010-05-19       Impact factor: 3.064

3.  Multicentre results of stereotactic body radiotherapy for secondary liver tumours.

Authors:  Betul Berber; Rafael Ibarra; Laura Snyder; Min Yao; Jeffrey Fabien; Michael T Milano; Alan W Katz; Karyn Goodman; Kevin Stephans; Galal El-Gazzaz; Federico Aucejo; Charles Miller; John Fung; Simon Lo; Mitchell Machtay; Juan Sanabria
Journal:  HPB (Oxford)       Date:  2013-01-14       Impact factor: 3.647

Review 4.  Options for radiotherapy in the treatment of liver metastases.

Authors:  Joan Manel Gasent Blesa; Laura A Dawson
Journal:  Clin Transl Oncol       Date:  2008-10       Impact factor: 3.405

5.  Novel application of stereotactic ablative radiotherapy using CyberKnife® for early-stage renal cell carcinoma in patients with pre-existing chronic kidney disease: Initial clinical experiences.

Authors:  Cheng-Hsiang Lo; Wen-Yen Huang; Hsing-Lung Chao; Kuen-Tze Lin; Yee-Min Jen
Journal:  Oncol Lett       Date:  2014-05-09       Impact factor: 2.967

6.  Isolated colorectal liver metastases locally progressing after stereotactic body radiotherapy rescued with surgery.

Authors:  J M Gasent Blesa; J Laforga Canales; A Alberola Soler; F Peiró Monzó; J Bertelli Puche; V Alberola Candel
Journal:  Curr Oncol       Date:  2009-09       Impact factor: 3.677

7.  Commissioning and quality assurance of a commercial stereotactic treatment-planning system for extracranial IMRT.

Authors:  Lu Wang; Jinsheng Li; Kamen Paskalev; Peter Hoban; Wei Luo; Lili Chen; Shawn McNeeley; Robert Price; Charlie Ma
Journal:  J Appl Clin Med Phys       Date:  2006-02-15       Impact factor: 2.102

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.